SCHEMBL23348407

SCHEMBL23348407

Cc1cc(C)c(-c2ccc3c(c2)c2ccc(-c4c(C)cc(C)cc4C)cc2n3-c2cc(-c3ccccc3)cc(-n3c4ccc(-c5c(C)cc(C)cc5C)cc4c4ccc(-c5c(C)cc(C)cc5C)cc43)c2C#N)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1C Q14123 2/20 0.35
PDE9A O76083 1/20 0.35
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
GRIA4 P48058 2/20 0.34
GAA P10253 1/20 0.34
GRIA2 P42262 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
PSMB5 P28074 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
KDM5B Q9UGL1 2/20 0.32
ADORA2A P29274 2/20 0.32
ADORA1 P30542 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23348235 0.90 KDM4E (0.34) ALDH1A1KDM4EGRIA4GRIA2
SCHEMBL23348226 0.88 SMN1; SMN2 (0.36) PDE1CPDE9AALDH1A1KDM4EHPGD
SCHEMBL23348520 0.88 KDM5B (0.36) ALDH1A1KDM4EHPGDGRIA4GAA
SCHEMBL23348229 0.88 KCNJ5 (0.30) KDM4E
SCHEMBL19908998 0.87 PDE9A (0.35) PDE1CPDE9AALDH1A1
SCHEMBL23348232 0.87 PDE1C (0.33) PDE1CPDE9AALDH1A1KDM4EHPGD
SCHEMBL19909229 0.87 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDSMN1; SMN2MEN1
SCHEMBL21414241 0.87 PDE9A (0.36) PDE1CPDE9AALDH1A1KDM4EHPGD
SCHEMBL19909234 0.86 ALDH1A1 (0.41) PDE1CPDE9AALDH1A1KDM4EHPGD
SCHEMBL21546830 0.86 ALDH1A3 (0.34) PDE1CPDE9AALDH1A1GRIA4GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139425-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CCND2, CCND1, CRY1 PDE1C 4812/4885PDE9A 3859/4885ALDH1A1 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.